Nutex Health Insider Bamburg Files Form 4 on Ownership Change

TL;DR

**Nutex Health insider Bamburg filed a Form 4, signaling a change in his stock ownership.**

AI Summary

This Form 4 filing, dated March 24, 2026, indicates that Wesley Shane Bamburg, an insider at Nutex Health Inc., has filed a statement of changes in beneficial ownership of securities. While the filing itself doesn't detail specific transactions, it signals that Bamburg's ownership stake in Nutex Health may have changed as of the report period, March 11, 2026. This matters to investors because changes in insider ownership can sometimes signal management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock price.

Why It Matters

Changes in insider holdings can provide clues about how those closest to the company view its future, which can be a significant factor for investors.

Risk Assessment

Risk Level: low — This filing is purely administrative, reporting a change in ownership, and does not inherently indicate a high risk.

Analyst Insight

A smart investor would review the full primary document of this Form 4 to understand the specific nature and size of the transactions made by Wesley Shane Bamburg, as this could indicate insider confidence or concerns about Nutex Health Inc.'s future.

Key Players & Entities

• Bamburg Wesley Shane (person) — Reporting insider for Nutex Health Inc.
• Nutex Health Inc. (company) — The issuer of the securities.
• March 24, 2026 (date) — Filing date of the Form 4.
• March 11, 2026 (date) — Period of report for the Form 4.

Forward-Looking Statements

• The full details of Bamburg Wesley Shane's transactions will be available in the primary document of this filing. (Bamburg Wesley Shane) — high confidence, target: 2026-03-24
• Investors will analyze the specific transactions reported to gauge insider sentiment towards Nutex Health Inc. (Nutex Health Inc.) — medium confidence, target: 2026-03-25

FAQ

Key Financial Figures

• $0.001 — one share of the issuer's common stock, $0.001 par value, upon vesting. 2. On March 1

Filing Documents

• primary_doc.html (4)
• primary_doc.xml (4) — 4KB
• 0002093295-26-000001.txt ( ) — 6KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Bamburg Wesley Shane (Last) (First) (Middle) 1776 YORKTOWN STREET C/O NUTEX HEALTH INC. (Street) HOUSTON TEXAS 77056 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Nutex Health Inc. [ NUTX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Operating Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/11/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Units $ 0 (1) 03/11/2026 M 2,411 (1) 03/01/2027 (2) 03/01/2029 (2) Common Stock 2,411 $ 0 2,411 D Explanation of Responses: 1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. 2. On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. /s/ Wesley Shane Bamburg 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR